The current system for pregnancy and postnatal blood clot risk assessments is inadequate and could place pregnant women/people at risk of needing follow-on treatment or potentially fatal outcomes, a ...

Significant predictors of VTE were APACHE II score, previous immobilization, femoral central venous catheter, and invasive mechanical ventilation. Common risk assessment models for predicting venous ...

Every detail matters. In healthcare, small actions can lead to big outcomes—and sometimes, those outcomes save lives. An often-overlooked threat in outpatient care is Venous Thromboembolism (VTE), ...

Before the development of a formal VTE prophylaxis program, we needed to assess our current compliance with VTE prophylaxis, as the data from 2003 were not recent enough to accurately reflect current ...

Preventing venous thromboembolism (VTE) in hospitalized patients requires better risk assessment, increased awareness of the problem, and standardized tracking of patients at a national level, ...

In a head-to-head comparison study, the researchers described the discriminative performance of all RAMs as “poor.” Validated risk assessment models (RAMs) for venous thromboembolism (VTE) among ...

The researchers found that per 10,000 person-years, the standardized VTE rates were 2.0, 10.0, 8.0, 8.1, 3.6, 2.1, 3.4, and 11.9 for nonuse, combined pills, vaginal ...

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts Using retrospective data from ...

Prevalence, risk factors, and sequelae of long-term chemotherapy-induced peripheral neuropathy (CIPN) among breast cancer survivors. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting ...

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.

Patients with multiple myeloma are at increased risk for blood clots, especially in the first 6 to 12 months after treatment initiation. Many physicians advise no more than a daily aspirin to avoid ...